Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
WIPI2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
WDR54 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERVK3-1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEACAM21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
CCZ1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CUL4A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDCD6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPIE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101060835 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZDHHC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GNA11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZMIZ2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP6V1E1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPECC1L-ADORA2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FZD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARL6IP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on